E21 - Innovation Infrastructure and Future of Synthetic Biology | Jodi Barrientos CEO, Ribbon Bio

In this episode, we sit down with Jodi Barrientos, CEO of Ribbon Bio, to explore how innovation infrastructure is shaping the future of synthetic biology—and why scalable DNA manufacturing is critical to unlocking the next generation of biological breakthroughs.Jodi shares her journey from bench scientist to biotech entrepreneur, reflecting on the pivotal moments that inspired her to build a deep-tech company at the intersection of science, engineering, and advanced manufacturing. She discusses the founding vision behind Ribbon Bio and the mission to overcome longstanding limitations in traditional DNA synthesis technologies.At the core of the conversation is the challenge of engineering long, complex, high-fidelity DNA constructs—an essential capability for advancing therapeutics, vaccines, agriculture, and industrial biotechnology. Jodi explains how integrating automation, precision engineering, and computational tools enables a new level of scalability and reliability in synthetic DNA production. By combining advanced manufacturing principles with biological design, Ribbon Bio is building the infrastructure needed to accelerate innovation across the life sciences ecosystem.We also examine the growing role of computational tools and AI in DNA design—how digital modeling and predictive systems can optimize sequence construction, reduce errors, and streamline development cycles. Jodi highlights the commercialization challenges inherent in deep-tech biotech, from capital intensity to long development timelines, and shares leadership lessons learned while building resilient, highly technical teams.Episode Highlights:Ribbon Bio’s approach to redefining synthetic DNA manufacturingWhy scalable innovation infrastructure is critical for biotech growthHow precision, automation, and computational tools transform bioengineeringInsights into leading and scaling a deep-tech companyA forward-looking perspective on programmable biology and its impact across industriesThis episode offers valuable insights for biotech founders, synthetic biology innovators, investors, and scientist-entrepreneurs seeking to understand how infrastructure, scale, and precision will define the future of programmable biology.